PROLENSA vs XIFYRM

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Possible drug interaction. PROLENSA and XIFYRM are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	PROLENSA	XIFYRM
Rating	New	70/100
Pharmacy pays	$14.72 /mL	~$0.56 /30
Type	RX	RX
Active ingredient	BROMFENAC SODIUM	MELOXICAM
Manufacturer	Bausch and Lomb	Azurity
Dosage forms	Drops	Injectable
Drug class	Nonsteroidal Anti-Inflammatory Drug	Nonsteroidal Anti-Inflammatory Drug
Boxed warning	None	Boxed warning
Half-life	—	about 15 to 20 hours
Treats	Inflammation, Postoperative Pain, Eye Pain	Rheumatoid Arthritis, Osteoarthritis

prolensa xifyrm

Rating

New

70/100

Pharmacy pays

$14.72 /mL

~$0.56 /30

Type

Active ingredient

BROMFENAC SODIUM

MELOXICAM

Manufacturer

Bausch and Lomb

Azurity

Dosage forms

Drops

Injectable

Drug class

Nonsteroidal Anti-Inflammatory Drug

Boxed warning

None

Boxed warning

Half-life

—

about 15 to 20 hours

Treats

Inflammation, Postoperative Pain, Eye Pain

Rheumatoid Arthritis, Osteoarthritis

Frequently asked questions

What is the difference between Prolensa and Xifyrm?

Prolensa contains Bromfenac Sodium, while Xifyrm contains Meloxicam — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.